New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06487754

Enrollment

Registered

2024-07-05

Start date

2024-09-27

Completion date

2025-12-31

Last updated

2024-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gender-Affirming Care, Pelvic Pain, Testosterone, Transgender Persons

Brief summary

This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.

Detailed description

This study ai to accurately describe the chronic pelvic plan (CPP) from which transmasculine people can suffer, as well as their impact on quality of life, and to understand what are the obstacles and levers to the implementation of adapted care. Method: It is an observational, single-center, qualitative study. 10 to 15 trans individuals using testosterone therapy and having pelvic pain for at least 6 months, and that had appeared or changed since taking testosterone, will undergo a semi-structured interview. They will be recruited through community care associations, mailing lists and flyers. Results: This is a qualitative study aimed at accurately describing the symptoms of pelvic pain experienced by trans people thus we will do a qualitative analysis. QCAMAPS will be used for the coding step.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Being a trans masculine individual * Taking a gender affirming hormonal therapy (GAHT) * living close to Grenoble * having pelvic pain that appeared or were modified after taking GAHT

Exclusion criteria

* Subject under guardianship or subject deprived of liberty Refusal of voice recording

Design outcomes

Primary

Measure	Time frame	Description
Pelvic pain and impact on quality of life description	1.5 hours during semi structured interviews	Verbatim from the semi structured interviews

Secondary

Measure	Time frame	Description
pelvic pain intensity at the time of the interview	at the beginning of the interview	visual analog scale from 0 to 100 mm

Countries

France

Contacts

Primary ContactSaraEve Graham Longsworth, MSc

+33646820783

Outcome results